Climb Bio Statistics
NASDAQ: CLYMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
9.19-0.09 (-0.97%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Climb Bio by the numbers
Climb Bio has a market capitalization of $539.8 million based on 58.74M shares outstanding. With trailing EPS of $-0.81, Climb Bio is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 16.6% below its 50-day average and 14.8% below its 200-day average.
Average daily trading volume is 1.38M shares, or about $12.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CLYM valuation vs. peer median
| Metric | CLYM | Peer median | Difference |
|---|---|---|---|
| Market cap | $539.80M | $544.88M | -1% |
| Avg. volume | 1.38M | 1.28M | +7% |
Peer median across 8 companies: ACRS, AVBP, CBIO, ANL, BCAX, GERN, ZVRA, ALMS.
Valuation
- Market cap
- $539.80M
- EPS (TTM)
- $-0.81
- Shares outstanding
- 58.74M
Price and trading
- Previous close
- 9.28
- Open
- 8.94
- Day range
- 8.90 – 9.40
- 52-week range
- 1.64 – 18.33
- 52-week change
- +440.59%
- Beta
- —
- Volume
- 770.17K
- Average volume
- 1.38M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 539.80M
- Forward Pe
- -9.22
- Eps
- -0.81
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 18.33
- Week52 Low
- 1.64
- Avg Volume
- 1.38M
- Shares Outstanding
- 58.74M
- Ma50
- 11.01
- Ma200
- 10.79
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -49.86%
- Pct From52w Low
- 462.08%